chrX-155506930-GAT-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018196.4(TMLHE):βc.961_962delβ(p.Ile321LeufsTer5) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. I321I) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Exomes π: 9.1e-7 ( 0 hom. 1 hem. )
Failed GnomAD Quality Control
Consequence
TMLHE
NM_018196.4 frameshift
NM_018196.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.49
Genes affected
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-155506930-GAT-G is Pathogenic according to our data. Variant chrX-155506930-GAT-G is described in ClinVar as [Pathogenic]. Clinvar id is 225231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMLHE | NM_018196.4 | c.961_962del | p.Ile321LeufsTer5 | frameshift_variant | 6/8 | ENST00000334398.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMLHE | ENST00000334398.8 | c.961_962del | p.Ile321LeufsTer5 | frameshift_variant | 6/8 | 1 | NM_018196.4 | P1 | |
TMLHE | ENST00000369439.4 | c.961_962del | p.Ile321LeufsTer5 | frameshift_variant | 6/7 | 1 | |||
TMLHE-AS1 | ENST00000452506.1 | n.67+17544_67+17545del | intron_variant, non_coding_transcript_variant | 5 | |||||
TMLHE | ENST00000675642.1 | c.994_995del | p.Ile332LeufsTer5 | frameshift_variant | 7/9 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182885Hom.: 0 AF XY: 0.0000296 AC XY: 2AN XY: 67609
GnomAD3 exomes
AF:
AC:
2
AN:
182885
Hom.:
AF XY:
AC XY:
2
AN XY:
67609
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 9.12e-7 AC: 1AN: 1096216Hom.: 0 AF XY: 0.00000276 AC XY: 1AN XY: 362282
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1096216
Hom.:
AF XY:
AC XY:
1
AN XY:
362282
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Epsilon-trimethyllysine hydroxylase deficiency Pathogenic:2Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | This variant was found once in our laboratory maternally inherited in a 4-year-old male with autism, developmental delay/regression, speech delay. This patient has since been published (PMID:25943046). - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
risk factor, no assertion criteria provided | literature only | OMIM | Jul 27, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at